Global Medical REIT (NYSE:XRN - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "sell" rating to a "strong sell" rating in a report released on Saturday, Wall Street Zen reports.
Several other research analysts also recently weighed in on the company. Cantor Fitzgerald initiated coverage on Global Medical REIT in a research note on Monday, September 21st. They set an "overweight" rating and a $43.00 price target for the company. Huntington assumed coverage on Global Medical REIT in a research note on Wednesday, November 4th. They issued a "hold" rating on the stock. Citizens Jmp dropped their price objective on shares of Global Medical REIT from $42.00 to $35.00 and set a "market outperform" rating on the stock in a report on Wednesday, November 11th. Weiss Ratings lowered shares of Global Medical REIT from a "hold (c)" rating to a "hold (c-)" rating in a research report on Monday, November 9th. Finally, Zacks Research lowered shares of Global Medical REIT from a "hold" rating to a "strong sell" rating in a research report on Friday, November 13th. Two analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $38.60.
Check Out Our Latest Stock Report on XRN
Global Medical REIT Stock Down 0.6%
Global Medical REIT stock opened at $25.54 on Friday. Global Medical REIT has a twelve month low of $25.13 and a twelve month high of $38.65. The firm has a 50 day moving average price of $31.50 and a 200-day moving average price of $34.87. The company has a market capitalization of $338.34 million, a P/E ratio of 7.40 and a beta of 1.10. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 1.44.
Global Medical REIT (NYSE:XRN - Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The company reported ($0.67) EPS for the quarter, missing analysts' consensus estimates of $0.55 by ($1.22). The company had revenue of $40.34 million during the quarter. Global Medical REIT had a return on equity of 13.35% and a net margin of 36.80%. As a group, equities analysts predict that Global Medical REIT will post 2.80 EPS for the current year.
Institutional Trading of Global Medical REIT
An institutional investor recently raised its stake in Global Medical REIT stock. Marshall Wace LLP raised its holdings in shares of Global Medical REIT Inc. (NYSE:XRN - Free Report) by 5.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 19,412 shares of the company's stock after acquiring an additional 1,068 shares during the period. Marshall Wace LLP owned about 0.15% of Global Medical REIT worth $675,000 at the end of the most recent reporting period. Institutional investors own 57.52% of the company's stock.
Global Medical REIT Company Profile
(
Get Free Report)
Global Medical REIT, Inc. is a healthcare-focused real estate investment trust that acquires and owns purpose-built medical facilities. It leases these properties to healthcare providers, including physician groups and health systems, that use them to deliver patient care. The company's properties include medical office buildings, specialty hospitals, ambulatory surgery centers and inpatient rehabilitation facilities. Its leases are generally structured to provide long-term occupancy for tenants while supporting the company's rental-income business.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.